A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease

Conditions: Thyroid Eye Disease; Eye Diseases; Graves Ophthalmopathy; Graves Orbitopathy; Thyroid Associated Ophthalmopathy; Endocrine System Diseases; Orbital Diseases; Proptosis
Interventions: Drug: LASN01; Drug: LASN01; Drug: Placebo
Sponsors: Lassen Therapeutics Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 27, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments